Public confidence in U.S. health agencies slides, fueled by declines among Democrats
Reports and Proceedings
Updates every hour. Last Updated: 9-Nov-2025 10:11 ET (9-Nov-2025 15:11 GMT/UTC)
Public confidence in U.S. health and science agencies has dropped since the inauguration of President Donald Trump, according to a new survey by the Annenberg Public Policy Center. The survey also finds that most Americans lack confidence that Health and Human Services Secretary Robert F. Kennedy Jr. is providing the public with trustworthy information on matters of public health.
In the United States, Republican control of the House or presidency has often coincided with higher federal science appropriations, say Alexandar Furnas and colleagues in a Policy Forum. They base their findings – which challenge the conventional wisdom about partisan support for science – on an analysis of decades of U.S. science- and research-related appropriations data. “Overall, our findings highlight the complexity of the relationship between political control and federal science funding,” write the authors. “[The analysis] underscores the importance of framing science funding as a bipartisan priority that advances shared societal goals, while also calling for vigilance to protect science from political interference.” The United States government – the world’s largest research funder – plays a pivotal role in advancing scientific research and technological innovation worldwide. Even so, the connection between partisan control of the U.S. government and science funding has remained murky. This oversight is made more consequential in today’s polarized climate. To address this, Furnas et al. analyzed a detailed dataset of federal appropriations to science-related accounts from 1980 to 2020. Unlike prior studies that focus primarily on grantmaking, the analysis leverages a hand-collected database of 171 appropriations accounts across 27 federal agencies associated with science or research activity, encompassing the full range of science- and research-related expenditures authorized through the annual appropriations process. These accounts include not only grants to universities and external researchers but also contracts with private firms and in-house research conducted by federal agencies.
The findings show that federal science funding is far more complex than often assumed, with grants constituting only a small fraction of total appropriations. According to the authors, much of the money flows instead to private firms through contracts or to in-house agency research, highlighting the need to look beyond grantmaking to understand the full scope of federal investment. Notably, Furnas et al. also found that, contrary to the common perception that Republicans are hostile to science, Republican control of the House or presidency has often coincided with higher levels of science appropriations across multiple agencies, often averaging hundreds of millions more per account compared with Democratic control. Importantly, the authors show that, while the scale of funding fluctuates with partisan power, the distribution of grants across scientific fields remains largely stable. However, according to Furnas et al., given growing polarization and declining trust in science among some Republican policymakers, past patterns of support are no guarantee of what lies ahead.
Postpartum hemorrhage, severe bleeding after childbirth, is a leading cause of maternal mortality around the world. But many of these deaths can be prevented—and a real-time blood-monitoring technology called viscoelastic testing (VET) could play a crucial role. Though used in parts of Europe, VET is not yet a standard part of maternity care in the United States. A new sweeping review from the Southern California Evidence Review Center, part of the Keck School of Medicine of USC, brings U.S. hospitals a step closer to improving treatment of maternal hemorrhage with VET. The study, just published in the International Journal of Obstetric Anesthesia, includes a summary of findings from 156 research publications. The study was commissioned by the Patient-Centered Outcomes Research Institute (PCORI) and included interviews with patients, clinicians and policymakers. The review revealed that VET holds promise, but that high-quality research on its use for maternity care is limited. A major takeaway is the need for a large-scale, U.S.-based research study to test VET’s effectiveness in this context, as well as a broader professional consensus about when and how the technology should be applied. Insights from the report can help guide policy, research priorities and other key decisions around the use of this technology.
Health funders would likely have a better return on investment and a stronger position in the global funding crisis if Africans had greater decision-making influence and voting power in global health institutions.
This is an assertion in an article published on 15 September 2025 in the prestigious BMJ Global Health journal.